Hear.com Horizon Go IX vs JLab Hear OTC
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Hear.com Horizon Go IX
The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, listed at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #17 among 36 prescription hearing aids tested. This device demonstrates particular strength in speech clarity. Speech in quiet scored a strong 4.0/5, which is +0.72 points above the category average. Speech in noise performance also exceeded the category average by +0.61 points, though at 2.6/5 the absolute score remains mixed—meaning it handles challenging listening environments better than many competitors but still has room for improvement in demanding situations. The most notable limitation is own-voice comfort, scoring 1.8/5—a low result that falls 0.95 points below the category average. Users sensitive to how their own voice sounds may find this particularly noticeable. Feedback handling is strong in absolute terms at 4.4/5, though it sits slightly below the category average by 0.31 points. Music streaming performance is mixed at 2.7/5, essentially matching the category average. At this price point, the Horizon Go IX faces stiff competition. Same-price alternatives like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) deliver higher overall sound performance. Budget-conscious shoppers might also consider options like the Rexton Reach R-Li T80 at Costco, which achieves a higher score at a lower price. The Horizon Go IX is best suited for those prioritizing speech clarity who can accept the own-voice trade-off and prefer the hear.com service model.

JLab Hear OTC
The JLab Hear OTC is a budget-friendly OTC hearing aid priced at $100, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This visible-in-ear device ranks #36 of 65 OTC hearing aids tested, placing it in the top 54% of its category. In our testing, the JLab Hear OTC shows a distinctive performance profile with clear strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling also performs excellently at 5.0/5, providing stable amplification without whistling during our standardized challenge motions. These strengths make it particularly well-suited for users who prioritize streaming audio content. However, speech performance presents limitations. Speech in quiet scores 2.1/5, which is 0.67 points below the category average of 2.79. Speech in noise is more constrained at 1.0/5, falling 0.46 points below average. Own-voice comfort also scores low at 1.8/5, which is 0.71 points below the category norm. These results suggest the device may be less effective for primary speech amplification needs compared to alternatives in its price range. The JLab Hear OTC includes rechargeable batteries and supports both iPhone and Android streaming with hands-free functionality. At this price point, competitors like the Elehear Beyond (4.36/5) and Apple AirPods Pro 2 (4.06/5) offer stronger overall sound performance. This device may appeal most to budget-conscious users who value excellent streaming quality and feedback stability over speech enhancement capabilities.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Audio scenes
Using MUSHRA scenes (Tuned)
Fitting configuration for tuned fit